FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

32964011000001101: Selexipag 400microgram tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100459301000001110 Selexipag 400microgram tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100459401000001119 Selexipag 400microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selexipag 400microgram tablets Is a Selexipag true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Is a Selexipag false Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has active ingredient Vasodilator false Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 400microgram tablets (Janssen-Cilag Ltd) Is a True Selexipag 400microgram tablets Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets 60 tablet Has VMP True Selexipag 400microgram tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start